View Post

Reporting Real Time Events to Understand Adverse Events Sooner

In Blog, Clinical6 by Brandy ReedLeave a Comment

Written By: Kamei Triebell With more clinical trials involving evaluations of new drugs or vaccines, monitoring for early detection of adverse events is essential. Advances in technology have enhanced data capture capabilities, making more timely and accurate information available to drug developers. Through the use of electronic data capture and enterprise mobile technologies, potential adverse events can be understood faster. …

View Post

Q&A with Parallel 6 advisory board member James Flatt

In Blog, Clinical6 by Brandy ReedLeave a Comment

We sat down with advisory board member James Flatt, Ph.D. to discuss new innovations in the nutriceutical industry using enterprise mobile technology. Jim has been involved in the biotech industry for 25 years at prestigious organizations, including Synthetic Genomics Inc., Martek Biosciences, Merck, and Monsanto. As an advisory board member here at Parallel 6, he has helped us grow in …

View Post

Advances in Data Collection through Mobile Health Technology

In Clinical6 by Brandy ReedLeave a Comment

Written By: Kamei Triebell Mobile devices are a natural point of engagement for a majority of the population. According to the International Telecommunication Union, there are almost as many mobile telephone subscriptions today as there are people in the world. While most development data collection is still paper-based, there is a great amount of success resulting from data collection with …

View Post

3 Ways to Ensure the Patient During eQualification and eConsent

In Clinical6 by Brandy ReedLeave a Comment

Clinical trial software should be used to instill confidence in potential participants during the earliest stages of enrollment. Ensuring potential participants during eConsent and eQualification will not only accelerate enrollment, but also improve retention. Clinical trial software has the ability to provide personalized educational resources and a comprehensive platform for the study that demonstrates transparency, consistency, privacy, and confidentiality to the potential …

View Post

3 Tips for Conducting Clinical Research with Patient Pools That Have Multiple Languages

In Clinical6 by Brandy ReedLeave a Comment

The globalization of clinical trials is no longer a matter of speculation, it is a reality. Trials to continue to shift towards emerging markets such as China, Russia, and India in the search for more patients, lower costs, and faster recruitment. In 2005 as much as 40% of all drug trials conducted were in emerging markets, up from about 10% …